Stockreport

Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76 [Yahoo! Finance]

Context Therapeutics Inc.  (CNTX) 
PDF “The FDA's clearance of our IND marks an important achievement for Context, allowing us to proceed with the Phase 1 clinical program for this potentially best-in-class [Read more]